Aarti Drugs Ltd.
Snapshot View

View in App

Prices View details >>

419.50 +17.40 ▲4.3%

03 February 2023, 04:01:00 PM
Volume: 6,989

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aartidrugs.com
Market Cap 3,885.50 Cr.
Enterprise Value(EV) 4,466.67 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 17.88 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 23.46 Trailing Twelve Months Ending 2022-12
Industry PE 32.22 Trailing Twelve Months Ending 2022-12
Book Value / Share 123.82 Trailing Twelve Months Ending 2022-12
Price to Book Value 3.39 Calculated using Price: 419.50
Dividend Yield 0.24 Period Ending 2022-03
No. of Shares Subscribed 9.26 Cr. 92,600,000 Shares
FaceValue 10
Company Profile
Aarti Drugs (ADL), incorporated in 1984, is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.33%
1 Week
+2.18%
1 Month
-6.85%
3 Month
-9.59%
6 Month
+0.62%
1 Year
-18.23%
2 Year
-38.90%
5 Year
+183.60%
10 Year
+1400.36%

Ratios View Details >>

9 years 2011-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.18 32.78 20.65 21.60 19.24 17.97 23.65 35.81 21.03
Return on Capital Employed (%) 13.12 23.93 17.95 18.50 17.31 17.01 21.39 34.52 20.75
Return on Assets (%) 4.99 10.13 6.53 7.13 6.38 6.31 9.33 16.78 10.32

Balance Sheet View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 163 308 357 400 455 543 652 913 1,036 1,110
Non Curr. Liab. 290 211 244 297 312 321 301 257 232 225
Curr. Liab. 70 483 501 494 622 591 623 595 940 934
Minority Int. 0 0 0
Equity & Liab. 523 1,002 1,102 1,191 1,389 1,455 1,577 1,766 2,208 2,269
Non Curr. Assets 264 476 537 620 653 671 673 709 815 869
Curr. Assets 260 526 565 571 737 784 904 1,057 1,393 1,400
Misc. Exp. not W/O
Total Assets 523 1,002 1,102 1,191 1,389 1,455 1,577 1,766 2,208 2,269

Profit Loss View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 501 1,097 1,140 1,195 1,244 1,561 1,806 2,155 2,489 2,668
Other Income 0 1 4 1 2 1 5 11 4
Total Income 501 1,098 1,140 1,199 1,245 1,563 1,808 2,159 2,500 2,672
Total Expenditure -432 -925 -960 -1,005 -1,042 -1,350 -1,541 -1,714 -2,156 -2,370
PBIDT 69 173 180 194 203 213 267 445 344 302
Interest -17 -42 -48 -40 -38 -44 -37 -26 -24 -31
Depreciation -19 -31 -37 -38 -40 -43 -49 -50 -50 -50
Taxation -10 -22 -27 -34 -42 -41 -44 -89 -65 -56
Exceptional Items 4 4 0
PAT 24 77 69 82 82 90 141 280 205 166
Minority Interest 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit 24 77 69 82 82 90 141 280 205 166
Adjusted EPS 2 8 7 9 9 10 15 30 22 18

Cash Flow View Details >>

Particulars 10 years 2010-03 Rs. Cr. 2011-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 59 21 105 133 175 70 143 251 155 70
Cash Fr. Inv. -30 -76 -107 -99 -107 -74 -62 -33 -72 -149
Cash Fr. Finan. -24 53 1 -33 -68 4 -80 -215 -81 92
Net Change 5 -3 -1 1 0 0 1 2 2 13
Cash & Cash Eqvt 9 5 4 5 3 3 5 7 9 22

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 60.20 60.20 60.14 60.12 59.99 59.83 59.98 59.77 59.66
Public 39.80 39.80 39.86 39.88 40.01 40.17 40.02 40.23 40.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Q3 FY23 Earning Conference Call
Mon, 30 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of Conference Call
Fri, 27 Jan 2023
Board Meeting Outcome for Compliance Of Regulation 42(1)(A) And Regulation 43 Of The SEBI (LODR) Regulations 2015.
We wish to inform you that the Board of Directors of the Company at its Meeting held on Friday January 27 2023 has declared the Interim Dividend of Re. 1/- (Rupee One) (@10%) per Equity share of Rs. 10/- each for the financial year 2022-23

Technical Scans View Details >>

Fri, 03 Feb 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 5 Years High Increase in 5 Years
RSI Bullish RSI Bullish
William %R Bullish William %R Bullish

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Aarti Drugs Ltd.

What is Aarti Drugs share price?
Can I buy Aarti Drugs shares now?
What is the Dividend Yield of Aarti Drugs?
What is the Market Cap of Aarti Drugs?
What are the key metrics to analyse Aarti Drugs?
What is the 52 Week High and Low of Aarti Drugs?
What is the trend of Aarti Drugs share price?